| Bioactivity | Pradigastat sodium (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor. Pradigastat sodium has anti-obesity and anti-diabetic effects[1][2]. |
| Target | Diacylglycerol acyltransferase 1 (DGAT1) |
| CAS | 956136-98-4 |
| Formula | C25H23F3N3NaO2 |
| Molar Mass | 477.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Meyers CD, et al. Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome. Lipids Health Dis. 2015 Feb 18;14:8. [2]. Kulmatycki K, et al. Evaluation of a potential transporter-mediated drug interaction between ZD 4522 and pradigastat, a novel DGAT-1 inhibitor. Int J Clin Pharmacol Ther. 2015 May;53(5):345-55. |
Pradigastat sodium
CAS: 956136-98-4 F: C25H23F3N3NaO2 W: 477.45
Pradigastat sodium (LCQ-908) is a potent, selective and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.